Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 5/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.46 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.46 |
| ▸ | PRKDC | P78527 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | PIM3 | Q86V86 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3040456 | 0.82 | ERN1 (0.64) | ERN1CYP2A6HSP90AA1TLR9PTGDR2 | |
| SCHEMBL203395 | 0.80 | ERN1 (0.61) | ERN1CYP2A6PTGDR2ALDH1A1PTPN1 | |
| SCHEMBL1162125 | 0.80 | ERN1 (0.56) | ERN1CYP2A6HSP90AA1TLR9PTGDR2 | |
| SCHEMBL16765589 | 0.78 | ERN1 (0.59) | ERN1CYP2A6HSP90AA1TLR9PTGDR2 | |
| SCHEMBL29447322 | 0.78 | ALDH1A3 (0.48) | ERN1CYP2A6PRKDCALDH1A1LMNA | |
| SCHEMBL16247118 | 0.78 | ALDH1A3 (0.48) | ERN1CYP2A6PRKDCALDH1A1LMNA | |
| 5-Bromosalicylaldehyde SCHEMBL79219 | 0.76 | ERN1 (1.00) | ERN1PTGDR2CA12CA9LMNA | |
| SCHEMBL380473 | 0.76 | ERN1 (0.57) | ERN1PRKDCALDH1A1PTPN1S100A4 | |
| SCHEMBL144351 | 0.76 | ERN1 (0.57) | ERN1CYP2A6PTGDR2PRKDCALDH1A1 | |
| SCHEMBL18699 | 0.76 | ERN1 (0.57) | ERN1CYP2A6PTGDR2ALDH1A1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-118459420-A | Thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118459422-A | Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-114920907-B | Aminated porous aromatic skeleton compound and preparation method and application thereof | 福建农林大学 | 2023-06-20 | — | — | CN | claimed |
| CN-114920907-A | Aminated porous aromatic skeleton compound and preparation method and application thereof | 福建农林大学 | 2022-08-19 | — | — | CN | claimed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | claimed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | claimed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | claimed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | claimed |
| CN-102558184-B | Synthesis method of phthalazine derivative | UNIV SOUTHWEST | 2014-07-16 | — | — | CN | claimed |
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-4665730-A1 | HETEROCYCLIC GLP-1 AGONISTS | Gasherbrum Bio, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| US-12291529-B2 | Heterocyclic GLP-1 agonists | GASHERBRUM BIO, INC. (US) | 2025-05-06 | — | — | US | disclosed |
| WO-2025060786-A1 | SIX-MEMBERED AND FIVE-MEMBERED FUSED RING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 湘北威尔曼制药股份有限公司 | 2025-03-27 | — | — | WO | disclosed |
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | disclosed |
| EP-0247320-B1 | 5-ARYLALKYL-4-ALKOXY-2(5H)-FURANONES, INTERMEDIATES AND PROCESS FOR THEIR PREPARATION AS WELL AS THEIR APPLICATION AS THERAPEUTICALLY ACTIVE INGREDIENTS | SCHWABE WILLMAR GMBH & CO (DE) | 1990-12-27 | — | — | EP | disclosed |
| EP-0328669-A1 | CHALCONE DERIVATIVE COMPOUNDS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1989-08-23 | — | — | EP | disclosed |
| US-4855320-A | ANTICONVULSANTS, ANTIEPILEPTICS | DR. WILLMAR SCHWABE GMBH & COMPANY (DE) | 1989-08-08 | — | — | US | disclosed |
| EP-0247320-A2 | 5-Arylalkyl-4-alkoxy-2(5H)-furanones, intermediates and process for their preparation as well as their application as therapeutically active ingredients | Dr. Willmar Schwabe GmbH & Co. (DE) | 1987-12-02 | — | — | EP | disclosed |
| US-4450298-A | Vapor phase catalytic hydrolysis of benzal chloride or its halogen- or trifluoromethyl-substitute to form benzaldehyde or substitute | CENTRAL GLASS COMPANY, LIMITED (JP) | 1984-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12291529-B2 | Heterocyclic GLP-1 agonists | GLP1R, GIPR, IAPP | ERN1 2702/4885CYP2A6 2860/4885HSP90AA1 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.